SSGJ-613

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
107	若年性特発性関節炎	1

107. 若年性特発性関節炎

臨床試験数 : 447 / 薬物数 : 297 - (DrugBank : 57) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 146

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05027373 (ClinicalTrials.gov)	August 13, 2021	17/8/2021	Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1ß Humanized Monoclonal Antibody Inj ...	A Randomized, Double-blind, Placebo-controlled Parallel Trial of Safety, Tolerability and Pharmacoki ...	Systemic Juvenile Idiopathic Arthritis;Periodic Fever Syndrome	Drug: SSGJ-613;Drug: Placebo	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.	NULL	Recruiting	18 Years	45 Years	All	34	Phase 1	China

First Previous1Next Last